NH-130

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameNH-130
Drug Alias NameNH-130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor inverse agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsParkinson DiseaseParkinsonian Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson DiseaseParkinsonian Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A